Stay updated on Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A general NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T15:37:38.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T15:57:13.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The DREAMM-7 study page now displays a 403 Forbidden error, blocking access to the study details and related documents. The previous study content and PDFs listed on the page appear to have been removed or hidden.
    Difference
    19%
    Check dated 2026-09-22T22:00:20.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Added a publication reference on belantamab pricing in China and updated the page revision from v3.6.6 to v3.7.0.
    Difference
    0.1%
    Check dated 2026-09-15T22:12:52.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.6.6 and several non-core items (Multiple myeloma, related topics:, MedlinePlus Genetics, Revision: v3.6.5) were removed, indicating a templating or metadata update.
    Difference
    0.1%
    Check dated 2026-09-01T18:02:54.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page now includes a 2023 U.S. NIH grant/contract note. Related topic metadata now references MedlinePlus Genetics with the topic 'Multiple myeloma'.
    Difference
    0.1%
    Check dated 2026-08-25T20:39:27.000Z thumbnail image

Stay in the know with updates to Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page.